Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2

FEBS Letters

Volumn 580, Issue 14, 2006, Pages 3368-3374

  Sakai, Hideki ^a   Suzuki, Tomoyuki ^a   Takahashi, Yuji ^a   Ukai, Masashi ^a   Tauchi, Katsunori ^a   Fujii, Takuto ^a   Horikawa, Naoki ^a   Minamimura, Tetsuji ^a   Tabuchi, Yoshiaki ^b   Morii, Magotoshi ^a   Tsukada, Kazuhiro ^a   Takeguchi, Noriaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cancer cells; Carcinoma; Cell proliferation; Colon; Thromboxane

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; PROSTAGLANDIN H2; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ARTICLE; CANCER TISSUE; CATALYSIS; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDES; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; UP-REGULATION;

EID: 33646898794     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.007     Document Type: Article

References (34)

1. Grothey A., and Schmoll H.-.J. New chemotherapy approaches in colorectal cancer. Curr. Opin. Oncol. 13 (2001) 275-286
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature 411 (2001) 390-395
3. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
4. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., and Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55 (1995) 3785-3789
5. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
6. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann. Clin. Lab. Sci. 30 (2000) 3-21
7. Dormond O., Foletti A., Paroz C., and Rüegg C. NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nature Med. 7 (2001) 1041-1047
8. Marx J. Anti-inflammatories inhibit cancer growth - but how?. Science 291 (2001) 581-582
9. Thun M.J., Henley S.J., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94 (2002) 252-266
10. Wang D., Mann J.R., and DuBois R.N. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128 (2005) 1445-1461
11. Hawk E.T., Umar A., and Viner J.L. Colorectal cancer chemoprevention - an overview of the science. Gastroenterology 126 (2004) 1423-1447
12. Solomon D.H., Schneeweiss S., Glynn R.J., Kiyota Y., Levin R., Mogun H., and Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109 (2004) 2068-2073
13. Graham D.J., Campen D., Hui R., Spence M., Cheetham C., Levy G., Shoor S., and Ray W.A. Risk of acute myocardinal infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365 (2005) 475-481
14. Psaty B.M., and Furberg C.D. COX-2 inhibitors - lessons in drug safety. N. Engl. J. Med. 352 (2005) 1133-1135
15. Coleman R.A., Smith W.L., and Narumiya S. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46 (1994) 205-229
16. Carty E., Macey M., McCartney S.A., and Rampton D.S. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease. Aliment. Pharmacol. Ther. 14 (2000) 807-817
17. - secretion in isolated rat colon. J. Physiol. 505 (1997) 133-144
18. 2 in isolated human colon. J. Physiol. 562 (2005) 885-897
19. 2. J. Physiol. 543 (2002) 261-271
20. Morikawa K., Walker S.M., Nakajima M., Pathak S., Jessup J.M., and Fidler I.J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48 (1988) 6863-6871
21. - secretory mechanism of gastric parietal cells?. FEBS Lett. 575 (2004) 105-108
22. +-ATPase α3-isoform and down-regulation of the α1-isoform in human colorectal cancer. FEBS Lett. 563 (2004) 151-154
23. Tauchi K., Kakudo K., Machimura T., Makuuchi H., and Mitomi T. Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas. Cancer 67 (1991) 3042-3050
24. Newman P.J., Berndt M.C., Gorski J., White II G.C., Lyman S., Paddock C., and Muller W.A. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247 (1990) 1219-1222
25. Feuerstein N., and Ramwell P.W. OKY-1581, a potential selective thromboxane synthetase inhibitor. Eur. J. Pharmacol. 69 (1981) 533-534
26. Mikashima H., Ochi H., Muramoto Y., Yasuda H., Tsuruta M., and Maruyama Y. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function. Thromb. Res. 43 (1986) 455-468
27. 2 antagonist, on human, guinea pig and rat platelets. Jpn. J. Pharmacol. 59 (1992) 357-364
28. Nie D., Che M., Zacharek A., Qiao Y., Li L., Li X., Lamberti M., Tang K., Cai Y., Guo Y., Grignon D., and Honn K.V. Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am. J. Pathol. 164 (2004) 429-439
29. Moussa O., Yordy J.S., Abol-Enein H., Sinha D., Bissada N.K., Halushka P.V., Ghoneim M.A., and Watson D.K. Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 65 (2005) 11581-11587
30. Ikeda Y., Sugawara A., Taniyama Y., Uruno A., Igarashi K., Arima S., Ito S., and Takeuchi K. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor γ in macrophages via an interaction with NRF2. J. Biol. Chem. 275 (2000) 33142-33150
31. Yoshimatsu K., Golijanin D., Paty P.B., Soslow R.A., Jakobsson P.-.J., DeLellis R.A., Subbaramaiah K., and Dannenberg A.J. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 7 (2001) 3971-3976
32. Kamei D., Murakami M., Nakatani Y., Ishikawa Y., Ishii T., and Kudo I. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J. Biol. Chem. 278 (2003) 19396-19405
33. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276 (2001) 18075-18081
34. Δ716 mouse intestinal polyps. Cancer Res. 62 (2002) 506-511